Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

Chongqing Liangjiang New Area: intelligent development acceler...

CHONGQING, China, Apr. 16, 2020 /Xinhua-AsiaNet/-- According to Chongqing Liangjiang New Area Administrative Committee, Chongqing Liangjiang New Area ranked the first among all 14 regional n...

Workshop on Understanding Xi'an for International Friends, a c...

XI'AN, China, June 24, 2022 /Xinhua-AsiaNet/-- How do ancient and rich historical sites and modern urban life coexist harmoniously? On June 22, a number of international participants came to...

KVD Beauty Announces a New Global Director of Tattoo Artistry,...

SAN FRANCISCO, March 10, 2021 /PRNewswire-AsiaNet/ -- With a nonconformist and fearless spirit, KVD disrupted the industry in 2008 with its untraditional approach to beauty. When having tatt...

GEODIS appoints a New Regional Customs Brokerage Director in Asia-Pacific Region

Dr. Kian Chuan Chang joins GEODIS to take over as Regional Customs Brokerage Director  SINGAPORE - Media OutReach - 10 November 2020 - Dr. Chang has extensive experience ...

FOOMA JAPAN 2018, Largest Trade Show of "Food Machinery" and "...

TOKYO, Apr. 9, 2018 /Kyodo JBN-AsiaNet/ -- - Over 100,000 Visitors; Asia's Largest Trade Show for Food Technologies -FOOMA JAPAN (International Food Machinery & Technology Exhibition), w...

BioUrja Group has completed its acquisition of the operating b...

HOUSTON, Dec. 3, 2020 /PRNewswire-AsiaNet/ -- BioUrja Commodities, LLC, which is part of the BioUrja Group ("BioUrja") of Houston, TX, has completed its acquisition of the operating business...

TCAI Leader Participates in Clinical Trial for Catheter that M...

AUSTIN, Texas, Feb. 15, 2021 /PRNewswire-AsiaNet/-- A physician with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center (https://tcainstitute.com/ ) is among the fir...

MoneyHero Group Named Among the HR Asia Best Companies to Work for in Asia, Hong Kong 2024

SINGAPORE - Media OutReach Newswire - 17 May 2024 - MoneyHero Limited (NASDAQ: MNY) ("MoneyHero" or the "Company"), a market-leading personal finance and digital insurance aggregation and...

SinoMab Granted the Most Popular Newly Listed Company Award

HONG KONG, Jan 10, 2020 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen.

image

The 4th Hong Kong Golden Stocks Awards was jointly organized by Zhitongcaijing.com, China's leading information platform focusing on Hong Kong and US stock markets, and 10jka.com.cn. The "Most Popular Newly Listed Company" award aims at recognizing companies had been listed on Hong Kong Stock Exchange since 1 January 2019 with significant recognition from the industry, high participation of investors and excellent performance in capital markets. Being awarded the "Most Popular Newly Listed Company" demonstrates the industry and investors' close attention towards biotech industry and is a great encouragement and motivation for SinoMab's future success. SinoMab, as the first Hong Kong-listed local biopharmaceutical company, possesses several first-in-target and first-in-class drug candidates. As the drug candidate coming the closest to commercialization, the Company's flagship product SM03 is currently in Phase III clinical trial for RA in China and is expected to be marketed in 2021 the soonest. According to the latest statistics, approximately 300 patients have taken the treatment trial. Meanwhile, the Company has proactively carried out long-term development plan. Its Suzhou production base is expected to be put into operation by the end of 2021 to satisfy the commercialized production requirements of drug candidates in the future.

After three months of strict screening, the 4th Hong Kong Golden Stocks Awards attracted over 860 Hong Kong-listed companies to participate, covering emerging industries such as TMT and healthcare. The award is a recognition of SinoMab's R&D strengths, business model and industry influence from the market and investors and will help improving the Company's reputation in the capital market.

About SinoMab BioScience Limited SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis and is currently in Phase III clinical trial for rheumatoid arthritis in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis, systemic lupus erythematosus, non-Hodgkin's lymphoma, asthma, and other diseases with major unmet clinical needs.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastStreamEastjojobetcialis 20 mg fiyat